LATE SCLEROTIC PHASE DIAGNOSIS OF PAGET'S DISEASE OF BONE: A CASE REPORT
EPH - International Journal of Biological & Pharmaceutical Science · 2025
DOI: 10.53555/gwmgqm81 ↗Kurz gefasst
Fallbericht in der Zeitschrift EPH - International Journal of Biological & Pharmaceutical Science, 2025. Verfasst von Shafna. S und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Paget’s disease of bone (PDB), is a chronic skeletal disorder marked by abnormal bone remodeling due to increased osteoclastic activity followed by disorganized osteoblastic bone formation. It commonly affects older adults and present with pain, deformities, or fractures.
Methods
A 64-year-old male with Parkinsonism and hypertension, who reported chronic low back and groin pain. Laboratory evaluation revealed markedly elevated serum alkaline phosphatase (422.2 U/L), and MRI imaging showed suggestive of PDB in the late sclerotic phase.
Results
A single intravenous dose of zoledronic acid (5 mg) was administered, resulting in symptom relief and planned biochemical follow-up. Calcium and vitamin D supplementation were initiated to prevent treatment-related complications.
Conclusion
A multidisciplinary team involving physicians, clinical pharmacists, and nurses was critical in ensuring optimal care, preventing complications, and improving patient outcomes and quality of life.
Zitieren
APA
S, S., R, N., & Menaka, D. K. (2025). LATE SCLEROTIC PHASE DIAGNOSIS OF PAGET'S DISEASE OF BONE: A CASE REPORT. EPH - International Journal of Biological & Pharmaceutical Science. https://doi.org/10.53555/gwmgqm81
Vancouver
S S, R N, Menaka DK. LATE SCLEROTIC PHASE DIAGNOSIS OF PAGET'S DISEASE OF BONE: A CASE REPORT. EPH - International Journal of Biological & Pharmaceutical Science. 2025. doi:10.53555/gwmgqm81
BibTeX
@article{S2025,
author = {S, Shafna. and R, Neetikha and Menaka, Dr. K.},
title = {LATE SCLEROTIC PHASE DIAGNOSIS OF PAGET'S DISEASE OF BONE: A CASE REPORT},
journal = {EPH - International Journal of Biological & Pharmaceutical Science},
year = {2025},
doi = {10.53555/gwmgqm81}
}
EUVIMED